Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02982304 : Multi-Target Pallidal and Thalamic Deep Brain Stimulation for Hemi-Dystonia
PhasePhase 1
AgesMin: 18 Years Max: 65 Years
Eligibility
Inclusion Criteria:

1. Diagnosed with hemi-dystonia secondary to stroke

2. Candidate for GPi DBS

3. Able to provide informed consent

Exclusion Criteria:

1. History of intracranial pathology (such as multiple sclerosis, tumors, or aneurysms)
that may account for dystonia or essential tremor.

2. History or evidence of ongoing psychiatric or neurodegenerative disorders (such as
Parkinson's disease, Alzheimer's disease).

3. Incompetent adults or those unable to communicate.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02982304      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740